Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: A prospective controlled study

Acta Urologica Japonica

Volumn 46, Issue 5, 2000, Pages 301-306

  Maekawa, Shinya ^a   Suzuki, Hiroshi ^a   Ohkubo, Kazutoshi ^a   Aoki, Yoshitaka ^a   Okada, Takashi ^a   Maeda, Hiroshi ^a   Ogura, Keiji ^a   Arai, Yoichi ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Bladder cancer; Continuous intravesical instillation; Epirubicin

Indexed keywords

EPIRUBICIN; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER IRRIGATION; CANCER CHEMOTHERAPY; CANCER CONTROL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVESICAL; AGED; ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; HUMANS; IRRIGATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIOPERATIVE CARE; PREMEDICATION; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 0033946397     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Himman F Jr: The recurrence of bladder tumors. J Urol 75: 294-300, 1960
2. Pode D, Alon Y, Orowitz AT, et al.: The mechanism of human bladder tumor implantation in an in vitro model. J Urol 136 : 482-486, 1986
3. Kurth KH, Bouffioux C, Sylvester R, et al.: Is there an optimal treatment scheme for adjuvant introvesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitinal cell carcinoma of the bladder. Prog Clin Biol Res 269: 525-532, 1988
4. Bouffioux CH, Denis L, Oosterlinck W, et al.: Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of European Organization for Research and Treatment of Cancer randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. J Urol 148: 297-301, 1992
5. Fujita K: Intravesical antitumor therapy immediately after transurethral resection of the bladder cancer. Int J Urol 1: 341-344, 1994
6. Zincke H, Utz DC, Taylor WF, et al.: Influence of thiotepa and doxobubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective randomized double-blind, controlled trail. J Urol 129: 505-509, 1983
7. Burnand KG, Boyd PJR, Mayo ME, et al.: Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder cancer. Br J Urol 136: 55-59, 1976
8. Gavrell GJ, Lewis RW, Meehan WL, et al.: Intravesical thiotepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder. J Urol 120: 410-411, 1978
9. Oosterlinck W, Kurth KH, Schroder F, et al.: A prospective European Organization for Research and Treatment of Cancer genitourinary group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, Tl papillary carcinoma of the bladder. J Urol 149: 749-752, 1993
10. Ali-El-Dein B, Naveeh A, El-Baz M, et al. : Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pTl transitional cell bladder tumors: a prospective, randomized controlled study. Br J Urol 79: 731-735, 1997